Tag archive for ‘NERVENTRA® (laquinimod) for multiple sclerosis (MS)’
Jewish Business News Service On Sunday, January 26th, 2014

Teva and Active Biotech to Continue Laquinimod for Multiple Sclerosis Development Despite EMA

– Europe’s Committee for Medicinal Products for Human Use: The risk-benefit profile of laquinimod is not favorable at this time. –  – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) More...

Wordpress site Developed by Fixing WordPress Problems